Item Type | Name |
Concept
|
Colitis
|
Concept
|
Colitis, Ulcerative
|
Academic Article
|
Aminosalicylate therapy in the prevention of dysplasia and colorectal cancer in ulcerative colitis.
|
Academic Article
|
Superior mesenteric vein thrombosis after colectomy in a patient with Crohn's disease.
|
Academic Article
|
Are dysplasia and colorectal cancer endoscopically visible in patients with ulcerative colitis?
|
Academic Article
|
Surveillance of dysplasia in inflammatory bowel disease: The gastroenterologist-pathologist partnership.
|
Academic Article
|
Colonic infiltration with chronic myelomonocytic leukemia.
|
Academic Article
|
The challenge of compliance and persistence: focus on ulcerative colitis.
|
Academic Article
|
Positron emission tomography (PET) used to image subclinical inflammation associated with ulcerative colitis (UC) in remission.
|
Academic Article
|
Maximizing patient adherence and clinical outcomes with mesalamine in mildly-to-moderately active ulcerative colitis.
|
Academic Article
|
The impact of ulcerative colitis on patients' lives compared to other chronic diseases: a patient survey.
|
Academic Article
|
Open-label study of adalimumab in patients with ulcerative colitis including those with prior loss of response or intolerance to infliximab.
|
Academic Article
|
Outcome after surveillance of low-grade and indefinite dysplasia in patients with ulcerative colitis.
|
Academic Article
|
The peri-appendiceal red patch in ulcerative colitis: review of the University of Chicago experience.
|
Academic Article
|
Thromboembolic risk among Danish children and adults with inflammatory bowel diseases: a population-based nationwide study.
|
Academic Article
|
Colorectal cancer and dysplasia in inflammatory bowel disease.
|
Academic Article
|
Impact of ulcerative colitis from patients' and physicians' perspectives: Results from the UC: NORMAL survey.
|
Academic Article
|
Fecal bacteriotherapy for ulcerative colitis: patients are ready, are we?
|
Academic Article
|
Two brothers with skewed thiopurine metabolism in ulcerative colitis treated successfully with allopurinol and mercaptopurine dose reduction.
|
Academic Article
|
miR-143 and miR-145 are downregulated in ulcerative colitis: putative regulators of inflammation and protooncogenes.
|
Academic Article
|
When should ulcerative colitis patients undergo colectomy for dysplasia? Mismatch between patient preferences and physician recommendations.
|
Academic Article
|
Emerging issues in ulcerative colitis and ulcerative proctitis: individualizing treatment to maximize outcomes.
|
Academic Article
|
Total abdominal colectomy for refractory ulcerative colitis. Surgical treatment in evolution.
|
Academic Article
|
We once were blind and now we see: is it time to treat ulcerative colitis to achieve mucosal healing?
|
Academic Article
|
Claudin-1 and claudin-2 expression is elevated in inflammatory bowel disease and may contribute to early neoplastic transformation.
|
Academic Article
|
Will a 5-ASA a day keep the cancer (and dysplasia) away?
|
Academic Article
|
Genetic testing for inflammatory bowel disease: focus group analysis of patients and family members.
|
Academic Article
|
Low-dose smoking resumption in ex-smokers with refractory ulcerative colitis.
|
Academic Article
|
A diagnosis that eats at you.
|
Academic Article
|
Safety and effectiveness of long-term allopurinol-thiopurine maintenance treatment in inflammatory bowel disease.
|
Academic Article
|
Long-term treatment of patients with a history of ulcerative colitis who develop gastritis and pan-enteritis after colectomy.
|
Academic Article
|
Patient perceptions of fecal microbiota transplantation for ulcerative colitis.
|
Academic Article
|
What you see is not always what you get: raising the bar on clinical trial methodology in ulcerative colitis.
|
Academic Article
|
Fecal microbiota transplantation as therapy for inflammatory bowel disease: a systematic review and meta-analysis.
|
Academic Article
|
Patchy colitis and interstitial lung disease.
|
Academic Article
|
Inflammation is an independent risk factor for colonic neoplasia in patients with ulcerative colitis: a case-control study.
|
Academic Article
|
Optimal doses of methotrexate combined with anti-TNF therapy to maintain clinical remission in inflammatory bowel disease.
|
Academic Article
|
Assessment of the relationship between quality of sleep and disease activity in inflammatory bowel disease patients.
|
Academic Article
|
Curbing our enthusiasm for fecal transplantation in ulcerative colitis.
|
Academic Article
|
Clinical presentation and disease course of inflammatory bowel disease differs by race in a large tertiary care hospital.
|
Academic Article
|
Rescue therapy with cyclosporine or infliximab is not associated with an increased risk for postoperative complications in patients hospitalized for severe steroid-refractory ulcerative colitis.
|
Academic Article
|
Use of Serum Infliximab Level Prior to Cyclosporine Salvage Therapy in Severe Ulcerative Colitis.
|
Academic Article
|
Successful Treatment of Ulcerative Colitis With Vedolizumab in a Patient With an Infliximab-Associated Psoriasiform Rash.
|
Academic Article
|
U.S. Patients with Ulcerative Colitis Do Not Have a Decreased Risk of Diverticulosis.
|
Academic Article
|
Understanding Endoscopic Disease Activity in IBD: How to Incorporate It into Practice.
|
Academic Article
|
Surveillance of IBD Using High Definition Colonoscopes Does Not Miss Adenocarcinoma in Patients with Low-grade Dysplasia.
|
Academic Article
|
Patients with Ulcerative Colitis Are More Concerned About Complications of Their Disease than Side Effects of Medications.
|
Academic Article
|
Clostridium Difficile Infection in Ulcerative Colitis: Can Alteration of the Gut-associated Microbiome Contribute to Pouch Failure?
|
Academic Article
|
Recommendations for Quality Colonoscopy Reporting for Patients with Inflammatory Bowel Disease: Results from a RAND Appropriateness Panel.
|
Academic Article
|
Insights into the pathogenesis of ulcerative colitis from a murine model of stasis-induced dysbiosis, colonic metaplasia, and genetic susceptibility.
|
Academic Article
|
Activation of the Renin-Angiotensin System Promotes Colitis Development.
|
Academic Article
|
Current approaches for optimizing the benefit of biologic therapy in ulcerative colitis.
|
Academic Article
|
Serum 25-hydroxyvitamin D concentration is inversely associated with mucosal inflammation in patients with ulcerative colitis.
|
Academic Article
|
Baseline Oral 5-ASA Use and Efficacy and Safety of Budesonide Foam in Patients with Ulcerative Proctitis and Ulcerative Proctosigmoiditis: Analysis of 2 Phase 3 Studies.
|
Academic Article
|
Histological inflammation increases the risk of colorectal neoplasia in ulcerative colitis: a systematic review.
|
Academic Article
|
Ulcerative Colitis Remission Status After Induction With Mesalazine Predicts Maintenance Outcomes: the MOMENTUM Trial.
|
Academic Article
|
Many Inflammatory Bowel Disease Patients Are Not Immune to Measles or Pertussis.
|
Academic Article
|
Long-term Efficacy of Vedolizumab for Ulcerative Colitis.
|
Academic Article
|
Long-term Efficacy of Vedolizumab for Crohn's Disease.
|
Academic Article
|
Predicting Outcomes to Optimize Disease Management in Inflammatory Bowel Diseases.
|
Academic Article
|
Outcomes of colitis-associated dysplasia after referral from the community to a tertiary center.
|
Academic Article
|
Zinc Deficiency is Associated with Poor Clinical Outcomes in Patients with Inflammatory Bowel Disease.
|
Academic Article
|
When Subjects Violate the Research Covenant: Lessons Learned from a Failed Clinical Trial of Fecal Microbiota Transplantation.
|
Academic Article
|
Patient-Specific Bacteroides Genome Variants in Pouchitis.
|
Academic Article
|
The Crohn's and Colitis Foundation of America Survey of Inflammatory Bowel Disease Patient Health Care Access.
|
Academic Article
|
Assessment of corticosteroid-related quality of care measures for ulcerative colitis and Crohn's disease in the United States: a claims data analysis.
|
Academic Article
|
Efficacy of Vedolizumab Induction and Maintenance Therapy in Patients With Ulcerative Colitis, Regardless of Prior Exposure to Tumor Necrosis Factor Antagonists.
|
Academic Article
|
The Impact of Therapeutic Antibodies on the Management of Digestive Diseases: History, Current Practice, and Future Directions.
|
Academic Article
|
Histologic Normalization Occurs in Ulcerative Colitis and Is Associated With Improved Clinical Outcomes.
|
Academic Article
|
Early Transcriptomic Changes in the Ileal Pouch Provide Insight into the Molecular Pathogenesis of Pouchitis and Ulcerative Colitis.
|
Academic Article
|
Early Transcriptomic Changes in the Ileal Pouch Provide Insight into the Molecular Pathogenesis of Pouchitis and Ulcerative Colitis.
|
Academic Article
|
Communication Between Physicians and Patients with Ulcerative Colitis: Reflections and Insights from a Qualitative Study of In-Office Patient-Physician Visits.
|
Academic Article
|
Budesonide Multimatrix Is Efficacious for Mesalamine-refractory, Mild to Moderate Ulcerative Colitis: A Randomised, Placebo-controlled Trial.
|
Academic Article
|
Indicators of suboptimal biologic therapy over time in patients with ulcerative colitis and Crohn's disease in the United States.
|
Academic Article
|
Faecal Microbiota Transplantation for Inflammatory Bowel Disease: A Systematic Review and Meta-analysis.
|
Academic Article
|
miR-193a-3p is a Key Tumor Suppressor in Ulcerative Colitis-Associated Colon Cancer and Promotes Carcinogenesis through Upregulation of IL17RD.
|
Academic Article
|
miR-4728-3p Functions as a Tumor Suppressor in Ulcerative Colitis-associated Colorectal Neoplasia Through Regulation of Focal Adhesion Signaling.
|
Academic Article
|
Patients With Ulcerative Colitis and Primary Sclerosing Cholangitis Frequently Have Subclinical Inflammation in the Proximal Colon.
|
Academic Article
|
Vedolizumab as Induction and Maintenance for Inflammatory Bowel Disease: 12-month Effectiveness and Safety.
|
Academic Article
|
Assessment of peri-polyp biopsy specimens of flat mucosa in patients with inflammatory bowel disease.
|
Academic Article
|
Tofacitinib in Patients with Ulcerative Colitis: Health-Related Quality of Life in Phase 3 Randomised Controlled Induction and Maintenance Studies.
|
Academic Article
|
Corrigendum: Budesonide Multimatrix Is Efficacious for Mesalamine-refractory, Mild to Moderate Ulcerative Colitis: A Randomised, Placebo-controlled Trial.
|
Academic Article
|
Tofacitinib in Patients with Ulcerative Colitis: Health-Related Quality of Life in Phase 3 Randomised Controlled Induction and Maintenance Studies.
|
Academic Article
|
Burden of Ulcerative Colitis on Functioning and Well-being: A Systematic Literature Review of the SF-36® Health Survey.
|
Academic Article
|
Clinical Response and Complications are not Associated with Drug Levels in Patients with Severe Ulcerative Colitis on IV Cyclosporine Induction Therapy.
|
Academic Article
|
Incidence of Arthritis/Arthralgia in Inflammatory Bowel Disease with Long-term Vedolizumab Treatment: Post Hoc Analyses of the GEMINI Trials.
|
Academic Article
|
Enteric infections complicating ulcerative colitis.
|
Academic Article
|
Increased mucosal expression of miR-215 precedes the development of neoplasia in patients with long-standing ulcerative colitis.
|
Academic Article
|
Higher Thioguanine Nucleotide Metabolite Levels are Associated With Better Long-term Outcomes in Patients With Inflammatory Bowel Diseases.
|
Academic Article
|
Fecal Calprotectin in Assessing Endoscopic and Histological Remission in Patients with Ulcerative Colitis.
|
Academic Article
|
Efficacy of Vedolizumab in Fistulising Crohn's Disease: Exploratory Analyses of Data from GEMINI 2.
|
Academic Article
|
Impact of a Patient Support Program on Patient Adherence to Adalimumab and Direct Medical Costs in Crohn's Disease, Ulcerative Colitis, Rheumatoid Arthritis, Psoriasis, Psoriatic Arthritis, and Ankylosing Spondylitis.
|
Academic Article
|
Efficacy and Follow-up of Segmental or Subtotal Colectomy in Patients With Colitis-Associated Neoplasia.
|
Academic Article
|
Real-World Experience with Tofacitinib in IBD at a Tertiary Center.
|
Academic Article
|
IBD-associated Colon Cancers Differ in DNA Methylation and Gene Expression Profiles Compared With Sporadic Colon Cancers.
|
Academic Article
|
Randomised clinical trial: delayed-release oral mesalazine 4.8 g/day vs. 2.4 g/day in endoscopic mucosal healing--ASCEND I and II combined analysis.
|
Academic Article
|
Systematic review: impact of non-adherence to 5-aminosalicylic acid products on the frequency and cost of ulcerative colitis flares.
|
Academic Article
|
Effects of vedolizumab on health-related quality of life in patients with ulcerative colitis: results from the randomised GEMINI 1 trial.
|
Academic Article
|
Real-world assessment of therapy changes, suboptimal treatment and associated costs in patients with ulcerative colitis or Crohn's disease.
|
Academic Article
|
Abnormal Pouchogram Predicts Pouch Failure Even in Asymptomatic Patients.
|
Academic Article
|
Low-Dose Metronidazole is Associated With a Decreased Rate of Endoscopic Recurrence of Crohn's Disease After Ileal Resection: A Retrospective Cohort Study.
|
Academic Article
|
ACG Clinical Guideline: Ulcerative Colitis in Adults.
|
Academic Article
|
Faecal Calprotectin Is a Very Reliable Tool to Predict and Monitor the Risk of Relapse After Therapeutic De-escalation in Patients With Inflammatory Bowel Diseases.
|
Academic Article
|
Ciclosporin Therapy After Infliximab Failure in Hospitalized Patients With Acute Severe Colitis is Effective and Safe.
|
Academic Article
|
Renin-angiotensin system promotes colonic inflammation by inducing TH17 activation via JAK2/STAT pathway.
|
Academic Article
|
Histologic Remission in Ulcerative Colitis: Are We There Yet?
|
Academic Article
|
The Cost of Inflammatory Bowel Disease: An Initiative From the Crohn's & Colitis Foundation.
|
Academic Article
|
Outcome of elective switching to vedolizumab in inflammatory bowel disease patients under tumor necrosis factor antagonist-maintained clinical remission.
|
Academic Article
|
Ustekinumab Is Effective for the Treatment of Chronic Antibiotic-Refractory Pouchitis.
|
Academic Article
|
Follow-Up of Patients With Ulcerative Colitis and Histological Normalization.
|
Academic Article
|
Comparison of the EMA and FDA Guidelines on Ulcerative Colitis Drug Development.
|
Academic Article
|
Patient and physician preferences for ulcerative colitis treatments in the United States.
|
Academic Article
|
Exposure to Anti-tumor Necrosis Factor Medications Increases the Incidence of Pouchitis After Restorative Proctocolectomy in Patients With Ulcerative Colitis.
|
Academic Article
|
Long-Duration Oral Vancomycin to Treat Clostridioides difficile in Patients With Inflammatory Bowel Disease Is Associated With a Low Rate of Recurrence.
|
Academic Article
|
Use of Tofacitinib for the Treatment of Arthritis Associated With Ulcerative Colitis.
|
Academic Article
|
Efficacy and safety of induction therapy with calcineurin inhibitors followed by vedolizumab maintenance in 71 patients with severe steroid-refractory ulcerative colitis.
|
Academic Article
|
Inpatient Management of Inflammatory Bowel Disease-Related Complications.
|
Academic Article
|
Cumulative Histologic Inflammation Predicts Colorectal Neoplasia in Ulcerative Colitis: A Validation Study.
|
Academic Article
|
Daily Aspirin Use Does Not Impact Clinical Outcomes in Patients With Inflammatory Bowel Disease.
|
Academic Article
|
Re: 18F-FDG PET-MR enterography in predicting histological active disease using the Nancy index in ulcerative colitis: a randomized controlled trial.
|
Academic Article
|
Management of Patients With Crohn's Disease and Ulcerative Colitis During the Coronavirus Disease-2019 Pandemic: Results of an International Meeting.
|
Academic Article
|
Segmental Histological Normalisation Occurs in Ulcerative Colitis but Does Not Improve Clinical Outcomes.
|
Academic Article
|
Corrigendum to The Cost of Inflammatory Bowel Disease: An Initiative From the Crohn's & Colitis Foundation.
|
Academic Article
|
Management of Acute Severe Ulcerative Colitis in a Pregnant Woman With COVID-19 Infection: A Case Report and Review of the Literature.
|
Academic Article
|
Efficacy of various endoscopic modalities in detecting dysplasia in ulcerative colitis: A systematic review and network meta-analysis.
|
Academic Article
|
Stopping Clinical Trials in Inflammatory Bowel Disease During the COVID-19 Pandemic Is Not a Responsible Act.
|
Academic Article
|
Safety of Tofacitinib in a Real-World Cohort of Patients With Ulcerative Colitis.
|
Academic Article
|
Efficacy of biosimilar infliximab CT-P13 among inpatients with severe steroid-refractory colitis.
|
Academic Article
|
Care of the Patient With IBD Requiring Hospitalisation During the COVID-19 Pandemic.
|
Academic Article
|
Diagnostic Accuracy of Fecal Calprotectin Concentration in Evaluating Therapeutic Outcomes of Patients With Ulcerative Colitis.
|
Academic Article
|
Relationship Between Combined Histologic and Endoscopic Endpoints and Efficacy of Ustekinumab Treatment in Patients With Ulcerative Colitis.
|
Academic Article
|
Long-term safety of vedolizumab for inflammatory bowel disease.
|
Academic Article
|
Cost-Effectiveness of 5-Aminosalicylate Therapy in Combination With Biologics or Tofacitinib in the Treatment of Ulcerative Colitis.
|
Academic Article
|
Ulcerative Colitis Narrative Global Survey Findings: Communication Gaps and Agreements Between Patients and Physicians.
|
Academic Article
|
The Impact of Intestinal Complications on Health Care Costs Among Patients With Inflammatory Bowel Disease Treated With Anti-Tumor Necrosis Factor Therapies.
|
Academic Article
|
Effective Treatment of Acute Severe Ulcerative Colitis in Pregnancy Is Associated With Good Maternal and Fetal Outcomes.
|
Academic Article
|
Histologic remission does not offer additional benefit for ulcerative colitis patients in endoscopic remission.
|
Academic Article
|
Outcomes of Tofacitinib Dose Reduction in Patients with Ulcerative Colitis in Stable Remission from the Randomised RIVETING Trial.
|
Academic Article
|
Inpatient Therapy With Calcineurin Inhibitors in Severe Ulcerative Colitis.
|
Academic Article
|
STRIDE-II: An Update on the Selecting Therapeutic Targets in Inflammatory Bowel Disease (STRIDE) Initiative of the International Organization for the Study of IBD (IOIBD): Determining Therapeutic Goals for Treat-to-Target strategies in IBD.
|
Academic Article
|
COVID-19 and Inflammatory Bowel Disease: Lessons Learned, Practical Recommendations, and Unanswered Questions.
|
Academic Article
|
International Perspectives on Management of Inflammatory Bowel Disease: Opinion Differences and Similarities Between Patients and Physicians From the IBD GAPPS Survey.
|
Academic Article
|
Endoscopic Phenotype of the J Pouch in Patients With Inflammatory Bowel Disease: A New Classification for Pouch Outcomes.
|
Academic Article
|
Vedolizumab and Anti-Tumour Necrosis Factor a Real-World Outcomes in Biologic-Naïve Inflammatory Bowel Disease Patients: Results from the EVOLVE Study.
|
Academic Article
|
Combining Cyclosporine With Ustekinumab in Acute Severe Ulcerative Colitis.
|
Academic Article
|
A Practical Clinical Approach to the Management of High-Risk Ulcerative Colitis.
|
Academic Article
|
Extraintestinal manifestations at baseline, and the effect of tofacitinib, in patients with moderate to severe ulcerative colitis.
|
Academic Article
|
Achieving Histologic Normalization in Ulcerative Colitis Is Associated With a Reduced Risk of Subsequent Dysplasia.
|
Academic Article
|
New targets in inflammatory bowel disease therapy: 2021.
|
Academic Article
|
Evolving role of endoscopy in inflammatory bowel disease: Going beyond diagnosis.
|
Academic Article
|
Older Adult Patients Use More Aminosalicylate Monotherapy Compared With Younger Patients With Inflammatory Bowel Disease: TARGET-IBD.
|
Academic Article
|
Diagnosis and classification of ileal pouch disorders: consensus guidelines from the International Ileal Pouch Consortium.
|
Academic Article
|
Stratifying Risks of Ileal Pouch Outcomes.
|
Academic Article
|
Inclusion of Under-represented Racial and Ethnic Minorities in Randomized Clinical Trials for Inflammatory Bowel Disease.
|
Academic Article
|
Ulcerative Colitis Patients Have Reduced Rectal Compliance Compared With Non-Inflammatory Bowel Disease Controls.
|
Academic Article
|
Worldwide post-marketing safety surveillance experience with tofacitinib in ulcerative colitis.
|
Academic Article
|
Etrolizumab versus adalimumab or placebo as induction therapy for moderately to severely active ulcerative colitis (HIBISCUS): two phase 3 randomised, controlled trials.
|
Academic Article
|
P028 Communicating Needs and Features of IBD Experiences (CONFIDE) Survey: Patient and Healthcare Professional Perspectives on Experience of Ulcerative Colitis Symptoms.
|
Academic Article
|
Outcomes of Ileoanal Pouch Anastomosis in Pediatric Ulcerative Colitis Are Worse in the Modern Era: A Time Trend Analysis Outcomes Following Ileal Pouch-Anal Anastomosis in Pediatric Ulcerative Colitis.
|
Academic Article
|
A Prospective Trial with Long Term Follow-up of Patients With Severe, Steroid-Resistant Ulcerative Colitis Who Received Induction Therapy With Cyclosporine and Were Maintained With Vedolizumab.
|
Academic Article
|
What Does Disease Progression Look Like in Ulcerative Colitis, and How Might It Be Prevented?
|
Academic Article
|
Entering the Era of Disease Modification in Inflammatory Bowel Disease.
|
Academic Article
|
Objective disease activity assessment and therapeutic drug monitoring prior to biologic therapy changes in routine inflammatory bowel disease clinical practice: TARGET-IBD.
|
Academic Article
|
IOIBD Recommendations for Clinical Trials in Ulcerative Proctitis: The PROCTRIAL Consensus.
|
Academic Article
|
Histopathology of Colectomy Specimens Predicts Endoscopic Pouch Phenotype in Patients with Ulcerative Colitis.
|
Academic Article
|
Assessment of the Degree of Variation of Histologic Inflammation in Ulcerative Colitis.
|
Academic Article
|
Ozanimod in the Treatment of Ulcerative Colitis: Initial Real-World Data From a Large Tertiary Center.
|
Academic Article
|
Identification of Risk Factors for Coexisting Sinusitis and Inflammatory Bowel Disease.
|
Academic Article
|
IL-23 Monoclonal Antibodies for IBD: So Many, So Different?
|
Academic Article
|
Intestinal Cancer and Dysplasia in Crohn's Disease.
|
Academic Article
|
Highlights in Ulcerative Colitis From the 17th Congress of the European Crohn's and Colitis Organisation: Commentary.
|
Academic Article
|
Upadacitinib Is Safe and Effective for Crohn's Disease: Real-World Data from a Tertiary Center.
|
Academic Article
|
Lifestyle, behaviour, and environmental modification for the management of patients with inflammatory bowel diseases: an International Organization for Study of Inflammatory Bowel Diseases consensus.
|
Academic Article
|
Serum Cytomegalovirus Polymerase Chain Reaction Test Is a Valuable Negative Predictor of Infection in Acute Severe Ulcerative Colitis.
|
Academic Article
|
Trends in Medical Management of Moderately to Severely Active Ulcerative Colitis: A Nationwide Retrospective Analysis.
|
Academic Article
|
CORE-IBD: A Multidisciplinary International Consensus Initiative to Develop a Core Outcome Set for Randomized Controlled Trials in Inflammatory Bowel Disease.
|
Academic Article
|
Global Hospitalization Trends for Crohn's Disease and Ulcerative Colitis in the 21st Century: A Systematic Review With Temporal Analyses.
|
Academic Article
|
Diagnostic and Management Considerations for the IPAA With Crohn's Disease-Like Features.
|
Academic Article
|
(Re)Appraising Remission in Ulcerative Colitis.
|
Academic Article
|
Efficacy and Safety of Ivarmacitinib in Patients With Moderate-to-Severe, Active, Ulcerative Colitis: A Phase II Study.
|
Academic Article
|
Ozanimod Maintenance Therapy After Cyclosporine Induction in Acute Severe Ulcerative Colitis.
|
Academic Article
|
Opportunistic Infections in Patients with Inflammatory Bowel Disease Treated with Advanced Therapies: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.
|
Academic Article
|
Endoscopic Management of Colitis-Associated Neoplasia.
|
Academic Article
|
Endo-histologic Normalization Is Achievable with Tofacitinib and Is Associated with Improved Clinical Outcomes.
|
Academic Article
|
Health-Related Quality of Life Outcomes With Tofacitinib Treatment in Patients With Ulcerative Colitis in the Open-Label Extension Study, OCTAVE Open.
|
Academic Article
|
Declining Enrolment and Other Challenges in IBD Clinical Trials: Causes and Potential Solutions.
|
Academic Article
|
Highlights in Ulcerative Colitis From Digestive Disease Week 2022: Commentary.
|
Academic Article
|
Treatment of Chronic Inflammatory Pouch Conditions With Tofacitinib: A Case Series From 2 Tertiary IBD Centers in the United States.
|
Academic Article
|
Methodology and Initial Results From a Real-World Observational Cohort of Patients With Inflammatory Bowel Disease: TARGET-IBD.
|
Academic Article
|
Real-World Experience With Proactive Therapeutic Drug Monitoring During Infliximab Reintroduction.
|
Academic Article
|
Real-World Effectiveness and Safety of Ustekinumab for Ulcerative Colitis From 2 Tertiary IBD Centers in the United States.
|
Academic Article
|
There Is No Substitute for Effective Education About Biosimilars.
|
Academic Article
|
Fecal Microbiota Transplantation for Ulcerative Colitis: An Evolving Therapy.
|
Academic Article
|
Listening to the Patient: Improving the Design and Conduct of Clinical Trials in Inflammatory Bowel Diseases.
|
Academic Article
|
Low Skeletal Muscle Index Adjusted for Body Mass Index Is an Independent Risk Factor for Inflammatory Bowel Disease Surgical Complications.
|
Academic Article
|
Inflammatory Bowel Disease Patients' Perspectives of Clinical Trials: A Global Quantitative and Qualitative Analysis.
|
Academic Article
|
A Clinical Predictive Model for One-year Colectomy in Adults Hospitalized for Severe Ulcerative Colitis.
|
Academic Article
|
Medically Refractory Lymphocytic Colitis Successfully Treated With Upadacitinib.
|
Academic Article
|
Upadacitinib Induction and Maintenance Therapy Improves Abdominal Pain, Bowel Urgency, and Fatigue in Patients With Ulcerative Colitis: A Post Hoc Analysis of Phase 3 Data.
|
Academic Article
|
Highlights in Ulcerative Colitis From the ACG Annual Scientific Meeting: Commentary.
|
Academic Article
|
Upadacitinib Is Effective and Safe in Both Ulcerative Colitis and Crohn's Disease: Prospective Real-World Experience.
|
Academic Article
|
Health-Related Quality of Life Outcomes With Tofacitinib Treatment in Patients With Ulcerative Colitis in the Open-Label Extension Study, OCTAVE Open
|
Academic Article
|
Transient Suppression of Bacterial Populations Associated with Gut Health is Critical in Success of Exclusive Enteral Nutrition for Children with Crohn's Disease.
|
Academic Article
|
Role and Impact of a Clinical Pharmacy Team at an Inflammatory Bowel Disease Center.
|
Academic Article
|
Major Adverse Cardiovascular Events by Baseline Cardiovascular Risk in Patients with Ulcerative Colitis Treated with Tofacitinib: Data from the OCTAVE Clinical Programme.
|
Academic Article
|
A Comparative Evaluation of the Measurement Properties of Three Histological Indices of Mucosal Healing in Ulcerative Colitis: Geboes Score, Robarts Histopathology Index and Nancy Index.
|
Academic Article
|
Development of the global inflammatory bowel disease visualization of epidemiology studies in the 21st century (GIVES-21).
|
Academic Article
|
Bowel Urgency in Ulcerative Colitis: Current Perspectives and Future Directions.
|
Academic Article
|
Clinician's Guide to Using Ozanimod for the Treatment of Ulcerative Colitis.
|
Academic Article
|
P028 Communicating Needs and Features of IBD Experiences (CONFIDE) Survey: Patient and Healthcare Professional Perspectives on Experience of Ulcerative Colitis Symptoms.
|
Academic Article
|
Efficacy and Safety of Approximately 3 Years of Continuous Ozanimod in Moderately to Severely Active Ulcerative Colitis: Interim Analysis of the True North Open-label Extension.
|
Academic Article
|
Presence of risk factors associated with colectomy among patients with ulcerative colitis: a post hoc analysis of data from the tofacitinib OCTAVE ulcerative colitis clinical program.
|
Academic Article
|
The Communicating Needs and Features of IBD Experiences (CONFIDE) Study: US and European Patient and Health Care Professional Perceptions of the Experience and Impact of Symptoms of Moderate-to-Severe Ulcerative Colitis.
|
Academic Article
|
Guselkumab in Patients With Moderately to Severely Active Ulcerative Colitis: QUASAR Phase 2b Induction Study.
|
Academic Article
|
Ozanimod-Exposed Patients with Ulcerative Colitis Undergoing Total Colectomy Exhibit Unique Lymph Node Histologic Changes.
|
Academic Article
|
At-home Disease Monitoring by Patient-performed Intestinal Ultrasound in Severe Ulcerative Colitis.
|
Academic Article
|
An Insight into Patients' Perspectives of Ulcerative Colitis Flares via Analysis of Online Public Forum Posts.
|
Academic Article
|
Impact of Baseline Corticosteroid Use on the Efficacy and Safety of Upadacitinib in Patients with Ulcerative Colitis: a Post Hoc Analysis of the Phase 3 Clinical Trial Programme.
|
Academic Article
|
Analysis of Clinical Trial Screen Failures in Inflammatory Bowel Diseases (IBD): Real World Results from the International Organization for the study of IBD.
|
Academic Article
|
Multiomic analysis reveals cellular and epigenetic plasticity in intestinal pouches of ulcerative colitis patients.
|
Academic Article
|
Real World Clinical Effectiveness and Safety of Ozanimod in the Treatment of Ulcerative Colitis: 1-Year Follow-Up from a Tertiary Center.
|
Academic Article
|
Association Between Smoking Status and the Efficacy and Safety of Tofacitinib in Patients with Ulcerative Colitis.
|
Academic Article
|
The evolving understanding of histology as an endpoint in ulcerative colitis.
|
Academic Article
|
Extensive Disease and Exposure to Multiple Biologics Precolectomy Is Associated with Endoscopic Cuffitis Post-Ileal Pouch-Anal Anastomosis in Patients With Ulcerative Colitis.
|